サンプル依頼リスト カート
  • English
  • Korean
表紙：CRISPRおよびCas遺伝子の世界市場：2023-2030年
市場調査レポート
商品コード
1380259

CRISPRおよびCas遺伝子の世界市場：2023-2030年

Global CRISPR and Cas Genes Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 200 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
CRISPRおよびCas遺伝子の世界市場：2023-2030年
出版日: 2023年09月26日
発行: Orion Market Research
ページ情報: 英文 200 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のCRISPRおよびCas遺伝子市場は予測期間（2023-2030年）に13.5%のCAGRで成長すると予測されます。CRISPR-Casシステムは、世界中の分子生物学研究所で最も広く使用されているゲノム編集技術です。ゲノムターゲットの改良に伴うCRISPRベースのスクリーニングの採用拡大が、世界の市場の成長を支える主要因です。米国国立衛生研究所（NIH）によると、2020年4月、CRISPRベースのスクリーンは、RNAiなどのアプローチと比較して、汎用性、有効性が向上し、オフターゲット効果が低いことが実証されました。ゲノムワイドCRISPRスクリーンは、低ノイズ、高いノックアウト効率、最小限のオフターゲット効果で、大規模な機能喪失スクリーニングを実施するための強力なツールとして登場しました。それゆえ、市場プレーヤーはCRISPRゲノムワイドノックアウトライブラリーソリューションの導入にも注力しており、市場成長をさらに後押ししています。例えば、2023年10月、Cellecta, Inc.はゲノムワイドCRISPRニワトリおよびブタノックアウトライブラリーを発表しました。Cellecta, Inc.は、ニワトリ（Gallus gallus）とブタ（Sus scrofa）用の新しいプールされた単一モジュールのCRISPRゲノムワイドノックアウトライブラリーをリリースしました。この新しいライブラリーにより、1回の実験で遺伝子破壊の研究が可能になり、品種改良などが可能になります。

米国立衛生研究所（NIH）によると、2022年12月時点では、CRISPR/Cas9が主流（85％）で、TALEN（3.0％）がこれに続いた。植物ではイネ（13.0％）、トマト（7.0％）、小麦・大麦（3％）が最も研究されており、動物ではブタ（7.0％）、ニワトリ（2.0％）、ウシ（2.0％）が主に研究されています。

セグメント別の展望

CRISPRおよびCAS遺伝子の世界市場では、ゲノムエンジニアリングのサブセグメントが大きなシェアを占めると予測されています。

用途の中でも、ゲノムエンジニアリングのサブセグメントが世界のCRISPRおよびCas遺伝子市場でかなりのシェアを占めると予想されています。このセグメントの成長は、病原性変異の修正、がん免疫療法に不可欠な遺伝子の探索、臓器異種移植における重要な問題の解決などの分野でCRISPRおよびCas技術の影響力が高まっていることに起因しています。CRISPRおよびCas遺伝子製品の発売は、ゲノムを編集し、遺伝子の機能を変更するという急成長分野に特化した専用ソリューションを示すものです。例えば、2021年6月、QIAGENは遺伝子編集実験を迅速かつ簡便に解析するためのCRISPR専用製品を発売しました。同社はQIAprep& CRISPR KitとCRISPR Q-Primer Solutionsを発売し、研究者が編集された遺伝物質を比類のないスピードと効率で解析し、介入によって問題のDNA配列の機能がどのように変化したかを判断できるようにしました。

地域別展望

世界のCRISPRおよびCas遺伝子市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、南米）を含む地域別にさらに細分化されます。このうち北米は、単純な遺伝子ノックアウト、選択的ゲノム切断、オフターゲット切断の低減、ゲノム工学、より高い特異性など、強化された個々の製品が利用可能であることから、全世界の市場で突出したシェアを占めると予想されています。主な市場プレイヤーとしては、Addgene Inc.、Danaher Corp.、GenScript Biotech、Takara Bio Inc.、Thermo Fisher Scientific, Inc.などが挙げられます。

アジア太平洋地域は世界のCRISPRおよびCas遺伝子市場において著しいCAGRで成長すると予想される

全地域の中で、アジア太平洋地域は予測期間中にかなりのCAGRで成長すると予測されています。同地域の成長は、新規治療法を開発するための研究開発への政府投資の増加が市場開拓を後押ししていることに起因します。例えば、2021年3月、日本のバイオテクノロジー企業であるセツローテックは、ダブリンを拠点とするERS Genomics社からCRISPR-Cas9技術の特許を取得しました。同社は、これらの先端技術を用いた動物モデルや細胞モデルの作製を進めています。このような取り組みにより、同地域におけるCRISPR技術の採用が促進され、収益創出にさらに貢献すると予測されます。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Danaher Corp.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • GenScript Biotech
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Thermo Fisher Scientific, Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Merck KGaA
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • CRISPRおよびCas遺伝子の世界市場：製品タイプ別
    • ベクターベースのCas
    • DNAフリーCas
  • CRISPRおよびCas遺伝子の世界市場：サービスタイプ別
    • 細胞株工学
    • gRNAデザイン
    • 微生物遺伝子編集
    • DNA合成
  • CRISPRおよびCas遺伝子の世界市場：用途別
    • ゲノム工学
    • 疾患モデル
    • 機能ゲノミクス
    • その他（エピジェネティクス、バイオメディカル）
  • CRISPRおよびCas遺伝子の世界市場：エンドユーザー別
    • バイオテクノロジー企業および製薬会社
    • 学術・政府研究機関
    • CRO（医薬品開発業務受託機関）

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • ACROBiosystems, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Caribou Biosciences, Inc.
  • Cell Biolabs, Inc.
  • Cellecta, Inc.
  • Creative Biogene.
  • CRISPR Therapeutics AG
  • Editas Medicine, Inc.
  • GE Healthcare
  • Horizon Discovery Group plc
  • Illumina, Inc.
  • Inscripta, Inc.
  • Integrated DNA Technologies, Inc.
  • Lonza Group AG
  • New England Biolabs
  • OriGene Technologies, Inc.
  • Qiagen NV
  • Synthego Corp.
  • Takara Bio Inc.
図表

LIST OF TABLES

  • 1. GLOBAL CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL VECTOR-BASED CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL DNA-FREE CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY SERVICE TYPE, 2022-2030 ($ MILLION)
  • 5. GLOBAL CRISPR AND CAS GENES FOR CELL LINE ENGINEERING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL CRISPR AND CAS GENES FOR GRNA DESIGN MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL CRISPR AND CAS GENES FOR MICROBIAL EDITING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL CRISPR AND CAS GENES FOR DNA SYNTHESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 10. GLOBAL CRISPR AND CAS GENES FOR GENOME ENGINEERING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL CRISPR AND CAS GENES FOR DISEASE MODELS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL CRISPR AND CAS GENES FOR FUNCTIONAL GENOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL CRISPR AND CAS GENES FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)
  • 15. GLOBAL CRISPR AND CAS GENES FOR BIOTECHNOLOGY COMPANIES & PHARMACEUTICAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. GLOBAL CRISPR AND CAS GENES FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. GLOBAL CRISPR AND CAS GENES FOR CROS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 18. GLOBAL CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 19. NORTH AMERICAN CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. NORTH AMERICAN CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 21. NORTH AMERICAN CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY SERVICE TYPE, 2022-2030 ($ MILLION)
  • 22. NORTH AMERICAN CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 23. NORTH AMERICAN CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)
  • 24. EUROPEAN CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 25. EUROPEAN CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 26. EUROPEAN CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY SERVICE TYPE, 2022-2030 ($ MILLION)
  • 27. EUROPEAN CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 28. EUROPEAN CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)
  • 29. ASIA- PACIFIC CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 30. ASIA- PACIFIC CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 31. ASIA- PACIFIC CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY SERVICE TYPE, 2022-2030 ($ MILLION)
  • 32. ASIA- PACIFIC CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 33. ASIA- PACIFIC CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)
  • 34. REST OF THE WORLD CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 35. REST OF THE WORLD CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 36. REST OF THE WORLD CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY SERVICE TYPE, 2022-2030 ($ MILLION)
  • 37. REST OF THE WORLD CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 38. REST OF THE WORLD CRISPR AND CAS GENES MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL CRISPR AND CAS GENES MARKET SHARE BY PRODUCT TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL VECTOR-BASED CRISPR AND CAS GENES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL DNA-FREE CRISPR AND CAS GENES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL CRISPR AND CAS GENES MARKET SHARE BY SERVICE TYPE, 2022 VS 2030 (%)
  • 5. GLOBAL CRISPR AND CAS GENES FOR CELL LINE ENGINEERING MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 6. GLOBAL CRISPR AND CAS GENES FOR GRNA DESIGN MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 7. GLOBAL CRISPR AND CAS GENES FOR MICROBIAL EDITING MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 8. GLOBAL CRISPR AND CAS GENES FOR DNA SYNTHESIS MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 9. GLOBAL CRISPR AND CAS GENES MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 10. GLOBAL CRISPR AND CAS GENES FOR GENOME ENGINEERING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL CRISPR AND CAS GENES FOR DISEASE MODELS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL CRISPR AND CAS GENES FOR FUNCTIONAL GENOMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL CRISPR AND CAS GENES FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL CRISPR AND CAS GENES MARKET SHARE BY END USERS, 2022 VS 2030 (%)
  • 15. GLOBAL CRISPR AND CAS GENES FOR BIOTECHNOLOGY COMPANIES & PHARMACEUTICAL MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. GLOBAL CRISPR AND CAS GENES FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 17. GLOBAL CRISPR AND CAS GENES FOR CROS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 18. GLOBAL CRISPR AND CAS GENES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 19. US CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. CANADA CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. UK CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. FRANCE CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. GERMANY CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. ITALY CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. SPAIN CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. REST OF EUROPE CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. INDIA CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. CHINA CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. JAPAN CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. SOUTH KOREA CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 31. REST OF ASIA-PACIFIC CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 32. LATIN AMERICA CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
  • 33. MIDDLE EAST AND AFRICA CRISPR AND CAS GENES MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027809

Title: Global CRISPR and Cas Genes Market Size, Share & Trends Analysis Report by Product Type (Vector-based Cas and DNA-free Cas), by Service Type (Cell Line Engineering, gRNA design, Microbial Gene Editing and DNA Synthesis), by Application (Genome Engineering, Disease Models, Functional Genomics and Other) and by End Users (Biotechnology Companies & Pharmaceutical, Academic and Government Research Institute and CROs),Forecast Period (2023-2030).

Global CRISPR and Cas genes market is anticipated to grow at a CAGR of 13.5% during the Forecast Period (2023-2030). CRISPR-Cas systems are the most widely used genome editing technology in molecular biology laboratories around the globe. The growing adoption of CRISPR-based screens with the improving genomic target is the key factor supporting the growth of the market globally. According to the National Institute of Health (NIH), in April 2020, CRISPR-based screens demonstrated improved versatility, efficacy, and lower off-target effects compared with approaches such as RNAi. Genome-wide CRISPR screen has emerged as a powerful tool for performing large-scale loss-of-function screens, with low noise, high knockout efficiency, and minimal off-target effects. Hence, the market players are also focusing on introducing CRISPR genome-wide knockout library solutions that further bolster the market growth. For instance, in October 2023, Cellecta, Inc. launched genome-wide CRISPR Chicken and Pig Knockout Libraries. Cellecta, Inc. released new pooled, single-module, CRISPR genome-wide knockout libraries for chicken (Gallus gallus) and pig (Sus scrofa). The new libraries allow the study of gene disruptions in a single experiment to enable improved breeding and more.

According to the National Institute of Health (NIH), in December 2022, CRISPR/Cas9 was the predominant tool (85%), followed by TALEN (3.0%). Rice (13.0%), tomato (7.0%), and wheat/barley (3%) were the most studied plants, whereas pig (7.0%), chicken (2.0%), and cow (2.0%) were the main animal species that were investigated.

Segmental Outlook

The global CRISPR and Cas genes market is segmented on the product type, service type, and industry verticals. Based on the product type, the market is sub-segmented into vector-based Cas and DNA-free Cas. Based on the service type, the market is sub-segmented into cell line engineering, gRNA design, microbial gene editing, and DNA synthesis. Based on the application, the market is sub-segmented into genome engineering, disease models, functional genomics, and others. Further, based on end users, the market is sub-segmented into biotechnology companies and pharmaceutical, academic, and government research institutes and CROs. Among the service types, the microbial gene editing sub-segment is anticipated to hold a considerable share of the market owing to the rise in the development of CRISPR-Cas9 which can be used to edit genes within microorganisms. This editing process has a wide variety of applications including basic biological research, development of biotechnological products, and treatment of diseases. ICRISPR-Cas systems have also been used for the treatment of other hematologic diseases, such as sickle cell disease (SCD) and hemophilia B (HB). It is not only limited to the treatment of genetic disorders but also it has been found effective for the treatment of metastatic cancer.

The Genome Engineering Sub-Segment is Anticipated to Hold a Considerable Share of the Global CRISPR and CAS genes Market

Among the applications, the genome engineering sub-segment is expected to hold a considerable share of the global CRISPR and Cas genes market. The segmental growth is attributed to the growing influence of CRISPR and Cas technology in the field of correcting pathogenic mutations, searching for essential genes for cancer immunotherapy, and solving key problems in organ xenotransplantation. CRISPR and Cas genes product launch marks dedicated solutions specific to the fast-growing field of editing genomes and modifying gene function. For instance, in June 2021, QIAGEN launched dedicated CRISPR Products for rapid and simplified analysis of gene-editing experiments. The company launched QIAprep& CRISPR Kit and CRISPR Q-Primer Solutions that allow researchers to analyze edited genetic material with unparalleled speed and efficiency to determine how their interventions have changed the function of the DNA sequence in question.

Regional Outlook

The global CRISPR and Cas genes market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to the availability of enhanced individual products such as simple gene knockouts, selective genome cleavage, reduced off-target cutting, genome engineering, and higher specificity. The key market players include Addgene Inc., Danaher Corp., GenScript Biotech, Takara Bio Inc., Thermo Fisher Scientific, Inc., and others.

The Asia-Pacific Region is Expected to Grow at a Significant CAGR in the Global CRISPR and Cas Genes Market

Among all regions, the Asia-Pacific region is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to increasing government investment in R&D to develop novel treatments is aiding in market expansion Japan and China are anticipated to support the region's growth. For instance, in March 2021, Japanese biotech company Setsuro Tech received a patent for CRISPR-Cas9 technology from Dublin-based ERS Genomics. The company is creating animal and cell models using these advanced technologies. Such initiatives are predicted to enhance CRISPR technology adoption in the region, further contributing towards revenue generation.

Market Players Outlook

The major companies serving the CRISPR and Cas Genes market include: Danaher Corp., GenScript Biotech, Merck KGaA, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, Qiagen NV, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in June 2020, Regeneron Pharmaceuticals, Inc. and Intellia Therapeutics, Inc. collaborated to provide Regeneron with rights to develop products for additional in vivo CRISPR/Cas9-based therapeutic targets and for the companies to jointly develop potential products for the treatment of hemophilia A and B.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global CRISPR and Cas genes market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Danaher Corp.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. GenScript Biotech
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Thermo Fisher Scientific, Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Merck KGaA
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global CRISPR and Cas Genes Market by Product Type
    • 4.1.1. Vector-based Cas
    • 4.1.2. DNA-free Cas
  • 4.2. Global CRISPR and Cas Genes Market by Service Type
    • 4.2.1. Cell Line Engineering
    • 4.2.2. gRNA Design
    • 4.2.3. Microbial Gene Editing
    • 4.2.4. DNA Synthesis
  • 4.3. Global CRISPR and Cas Genes Market by Application
    • 4.3.1. Genome Engineering
    • 4.3.2. Disease Models
    • 4.3.3. Functional Genomics
    • 4.3.4. Other (Epigenetics and Biomedical)
  • 4.4. Global CRISPR and Cas Genes Market by End Users
    • 4.4.1. Biotechnology Companies & Pharmaceutical
    • 4.4.2. Academic and Government Research Institute
    • 4.4.3. Contract Research Organizations (CROs)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. ACROBiosystems, Inc.
  • 6.2. Agilent Technologies, Inc.
  • 6.3. Bio-Rad Laboratories, Inc.
  • 6.4. Caribou Biosciences, Inc.
  • 6.5. Cell Biolabs, Inc.
  • 6.6. Cellecta, Inc.
  • 6.7. Creative Biogene.
  • 6.8. CRISPR Therapeutics AG
  • 6.9. Editas Medicine, Inc.
  • 6.10. GE Healthcare
  • 6.11. Horizon Discovery Group plc
  • 6.12. Illumina, Inc.
  • 6.13. Inscripta, Inc.
  • 6.14. Integrated DNA Technologies, Inc.
  • 6.15. Lonza Group AG
  • 6.16. New England Biolabs
  • 6.17. OriGene Technologies, Inc.
  • 6.18. Qiagen NV
  • 6.19. Synthego Corp.
  • 6.20. Takara Bio Inc.